

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | interferon-gamma secretion (GO:0072643) | 9.93618765 |
| 2 | desmosome organization (GO:0002934) | 9.82644934 |
| 3 | * keratinization (GO:0031424) | 9.71712758 |
| 4 | citrulline metabolic process (GO:0000052) | 9.56732630 |
| 5 | maintenance of gastrointestinal epithelium (GO:0030277) | 9.49328953 |
| 6 | long-chain fatty acid biosynthetic process (GO:0042759) | 9.43723487 |
| 7 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 8.94126853 |
| 8 | molting cycle (GO:0042303) | 8.78106634 |
| 9 | hair cycle (GO:0042633) | 8.78106634 |
| 10 | multicellular organismal water homeostasis (GO:0050891) | 8.71282422 |
| 11 | detection of other organism (GO:0098543) | 8.60732477 |
| 12 | lipoxygenase pathway (GO:0019372) | 8.24954125 |
| 13 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 7.87243969 |
| 14 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 7.87243969 |
| 15 | peptidyl-arginine modification (GO:0018195) | 7.80102267 |
| 16 | positive regulation of osteoblast proliferation (GO:0033690) | 7.58796237 |
| 17 | lung lobe morphogenesis (GO:0060463) | 7.54504968 |
| 18 | epithelial structure maintenance (GO:0010669) | 7.49178566 |
| 19 | linoleic acid metabolic process (GO:0043651) | 7.47180698 |
| 20 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 7.46534723 |
| 21 | lung vasculature development (GO:0060426) | 7.39625137 |
| 22 | regulation of natural killer cell differentiation (GO:0032823) | 7.27759539 |
| 23 | water homeostasis (GO:0030104) | 7.23673499 |
| 24 | keratinocyte proliferation (GO:0043616) | 7.14636987 |
| 25 | complement activation, alternative pathway (GO:0006957) | 7.01213553 |
| 26 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 7.01037042 |
| 27 | positive regulation of astrocyte differentiation (GO:0048711) | 6.63713558 |
| 28 | negative regulation of interferon-gamma production (GO:0032689) | 6.39264902 |
| 29 | hemidesmosome assembly (GO:0031581) | 6.27523616 |
| 30 | positive regulation of monocyte chemotaxis (GO:0090026) | 6.27115486 |
| 31 | sequestering of metal ion (GO:0051238) | 6.20554504 |
| 32 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 6.13975969 |
| 33 | sulfate transmembrane transport (GO:1902358) | 6.09593354 |
| 34 | negative regulation of interleukin-17 production (GO:0032700) | 5.69044042 |
| 35 | regulation of T cell chemotaxis (GO:0010819) | 5.66233863 |
| 36 | positive regulation of T cell chemotaxis (GO:0010820) | 5.66233863 |
| 37 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 5.55935606 |
| 38 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 5.51480846 |
| 39 | tyrosine phosphorylation of STAT protein (GO:0007260) | 5.49555911 |
| 40 | muscle organ morphogenesis (GO:0048644) | 5.47987204 |
| 41 | intermediate filament cytoskeleton organization (GO:0045104) | 5.38926394 |
| 42 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 5.30838332 |
| 43 | wound healing, spreading of epidermal cells (GO:0035313) | 5.25120952 |
| 44 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 5.24397945 |
| 45 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 5.23018484 |
| 46 | intermediate filament-based process (GO:0045103) | 5.22079391 |
| 47 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 5.11749171 |
| 48 | * keratinocyte differentiation (GO:0030216) | 5.11431390 |
| 49 | gap junction assembly (GO:0016264) | 5.09541987 |
| 50 | detection of external biotic stimulus (GO:0098581) | 5.07052223 |
| 51 | ectoderm development (GO:0007398) | 4.94798354 |
| 52 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.94597505 |
| 53 | response to host immune response (GO:0052572) | 4.94597505 |
| 54 | intermediate filament organization (GO:0045109) | 4.94545382 |
| 55 | sulfate transport (GO:0008272) | 4.91506333 |
| 56 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 4.76690710 |
| 57 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.60931147 |
| 58 | response to host (GO:0075136) | 4.60931147 |
| 59 | response to host defenses (GO:0052200) | 4.60931147 |
| 60 | regulation of monocyte chemotaxis (GO:0090025) | 4.57548986 |
| 61 | regulation of complement activation (GO:0030449) | 4.50805217 |
| 62 | 4-hydroxyproline metabolic process (GO:0019471) | 4.50801963 |
| 63 | * epidermis development (GO:0008544) | 4.48480843 |
| 64 | decidualization (GO:0046697) | 4.41590197 |
| 65 | detection of biotic stimulus (GO:0009595) | 4.33769333 |
| 66 | ceramide biosynthetic process (GO:0046513) | 4.31413187 |
| 67 | positive regulation of metanephros development (GO:0072216) | 4.27019621 |
| 68 | regulation of protein activation cascade (GO:2000257) | 4.18231657 |
| 69 | O-glycan processing (GO:0016266) | 4.18099038 |
| 70 | peptidyl-proline hydroxylation (GO:0019511) | 4.17997262 |
| 71 | defense response to fungus (GO:0050832) | 4.11465923 |
| 72 | defense response to Gram-negative bacterium (GO:0050829) | 4.06097143 |
| 73 | surfactant homeostasis (GO:0043129) | 4.02524588 |
| 74 | regulation of RIG-I signaling pathway (GO:0039535) | 4.02313181 |
| 75 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.00834026 |
| 76 | phosphatidylserine metabolic process (GO:0006658) | 3.96189756 |
| 77 | * epithelium development (GO:0060429) | 3.84667606 |
| 78 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.79164656 |
| 79 | positive regulation of macrophage differentiation (GO:0045651) | 3.78142952 |
| 80 | wound healing, spreading of cells (GO:0044319) | 3.77191038 |
| 81 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.74763888 |
| 82 | phospholipid catabolic process (GO:0009395) | 3.74164885 |
| 83 | * epidermal cell differentiation (GO:0009913) | 3.73502983 |
| 84 | antimicrobial humoral response (GO:0019730) | 3.69853591 |
| 85 | trophoblast giant cell differentiation (GO:0060707) | 3.66258040 |
| 86 | positive regulation of epidermis development (GO:0045684) | 3.65111970 |
| 87 | antibacterial humoral response (GO:0019731) | 3.62066259 |
| 88 | establishment of planar polarity (GO:0001736) | 3.61966057 |
| 89 | establishment of tissue polarity (GO:0007164) | 3.61966057 |
| 90 | regulation of apoptotic cell clearance (GO:2000425) | 3.61196667 |
| 91 | positive regulation of granulocyte chemotaxis (GO:0071624) | 3.49291304 |
| 92 | branching involved in salivary gland morphogenesis (GO:0060445) | 3.43002960 |
| 93 | keratinocyte development (GO:0003334) | 3.42731858 |
| 94 | regulation of osteoblast proliferation (GO:0033688) | 3.42353551 |
| 95 | chemical homeostasis within a tissue (GO:0048875) | 3.42345060 |
| 96 | innate immune response in mucosa (GO:0002227) | 3.41784456 |
| 97 | cell differentiation involved in embryonic placenta development (GO:0060706) | 3.41405916 |
| 98 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.41165684 |
| 99 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.41039759 |
| 100 | regulation of natural killer cell activation (GO:0032814) | 3.35121084 |
| 101 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.34399707 |
| 102 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.34104657 |
| 103 | positive regulation of histone acetylation (GO:0035066) | 3.28646032 |
| 104 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.21703590 |
| 105 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.17172304 |
| 106 | low-density lipoprotein particle clearance (GO:0034383) | 3.16647294 |
| 107 | regulation of interleukin-17 production (GO:0032660) | 3.12863028 |
| 108 | negative regulation of meiosis (GO:0045835) | 3.12740691 |
| 109 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.08867128 |
| 110 | regulation of axon regeneration (GO:0048679) | 3.07912386 |
| 111 | regulation of neuron projection regeneration (GO:0070570) | 3.07912386 |
| 112 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.07393017 |
| 113 | positive regulation of p38MAPK cascade (GO:1900745) | 3.05403084 |
| 114 | positive regulation of protein acetylation (GO:1901985) | 3.05117780 |
| 115 | positive regulation of peptidyl-lysine acetylation (GO:2000758) | 3.05117780 |
| 116 | alditol phosphate metabolic process (GO:0052646) | 3.01858379 |
| 117 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.00218835 |
| 118 | protein hydroxylation (GO:0018126) | 2.98004126 |
| 119 | * epithelial cell differentiation (GO:0030855) | 2.97275801 |
| 120 | positive regulation of T cell migration (GO:2000406) | 2.95143425 |
| 121 | regulation of water loss via skin (GO:0033561) | 2.93937565 |
| 122 | eyelid development in camera-type eye (GO:0061029) | 2.93468572 |
| 123 | mucosal immune response (GO:0002385) | 2.92999130 |
| 124 | negative regulation of viral release from host cell (GO:1902187) | 2.90847466 |
| 125 | cell-substrate junction assembly (GO:0007044) | 2.90052544 |
| 126 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.87756542 |
| 127 | regulation of T cell migration (GO:2000404) | 2.85173189 |
| 128 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.84679674 |
| 129 | negative regulation of cell fate specification (GO:0009996) | 2.83310948 |
| 130 | negative regulation of osteoclast differentiation (GO:0045671) | 2.83138421 |
| 131 | response to UV-B (GO:0010224) | 2.81360419 |
| 132 | response to fungus (GO:0009620) | 2.79781256 |
| 133 | phospholipid efflux (GO:0033700) | 2.78508976 |
| 134 | phosphatidylglycerol metabolic process (GO:0046471) | 2.76512718 |
| 135 | positive regulation of cholesterol efflux (GO:0010875) | 2.76342395 |
| 136 | regulation of humoral immune response (GO:0002920) | 2.75225370 |
| 137 | organ or tissue specific immune response (GO:0002251) | 2.74932973 |
| 138 | myotube differentiation (GO:0014902) | 2.73254589 |
| 139 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.72997533 |
| 140 | regulation of metanephros development (GO:0072215) | 2.72589632 |
| 141 | regulation of respiratory burst (GO:0060263) | 2.72582634 |
| 142 | cellular modified amino acid biosynthetic process (GO:0042398) | 2.69795149 |
| 143 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.67277241 |
| 144 | phosphatidic acid metabolic process (GO:0046473) | 2.66509145 |
| 145 | phosphatidic acid biosynthetic process (GO:0006654) | 2.66509145 |
| 146 | negative regulation of lymphocyte differentiation (GO:0045620) | 2.65583636 |
| 147 | skin morphogenesis (GO:0043589) | 2.61885068 |
| 148 | positive regulation of response to biotic stimulus (GO:0002833) | 2.61382754 |
| 149 | regulation of epidermis development (GO:0045682) | 2.59933215 |
| 150 | sphingolipid biosynthetic process (GO:0030148) | 2.59573353 |
| 151 | granulocyte differentiation (GO:0030851) | 2.55945796 |
| 152 | positive regulation of glial cell differentiation (GO:0045687) | 2.55491023 |
| 153 | digestive system process (GO:0022600) | 2.55451417 |
| 154 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.55054406 |
| 155 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.54237681 |
| 156 | fatty acid elongation (GO:0030497) | 2.52772193 |
| 157 | detection of bacterium (GO:0016045) | 2.51988589 |
| 158 | defense response to Gram-positive bacterium (GO:0050830) | 2.50446432 |
| 159 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.50015708 |
| 160 | cellular response to arsenic-containing substance (GO:0071243) | 2.47226009 |
| 161 | negative regulation of interleukin-6 production (GO:0032715) | 2.45899856 |
| 162 | positive regulation of cholesterol transport (GO:0032376) | 2.42794834 |
| 163 | positive regulation of sterol transport (GO:0032373) | 2.42794834 |
| 164 | regulation of keratinocyte differentiation (GO:0045616) | 2.40829581 |
| 165 | regulation of hair cycle (GO:0042634) | 2.40607370 |
| 166 | positive regulation of lymphocyte migration (GO:2000403) | 2.39517335 |
| 167 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.36604130 |
| 168 | positive regulation of humoral immune response (GO:0002922) | 2.35433271 |
| 169 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.34343352 |
| 170 | regulation of granulocyte chemotaxis (GO:0071622) | 2.33579519 |
| 171 | positive regulation of glomerulus development (GO:0090193) | 2.33107402 |
| 172 | defense response to bacterium (GO:0042742) | 2.32555820 |
| 173 | regulation of interleukin-6 production (GO:0032675) | 2.27708597 |
| 174 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.25535694 |
| 175 | response to zinc ion (GO:0010043) | 2.23012927 |
| 176 | hair follicle morphogenesis (GO:0031069) | 2.22721371 |
| 177 | establishment of skin barrier (GO:0061436) | 15.8342308 |
| 178 | citrulline biosynthetic process (GO:0019240) | 14.4998440 |
| 179 | peptide cross-linking (GO:0018149) | 11.0067617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.89229996 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.68503433 |
| 3 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.57372662 |
| 4 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 4.52807247 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.59102740 |
| 6 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.27948166 |
| 7 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.08512438 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.80583833 |
| 9 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.76321146 |
| 10 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.69244995 |
| 11 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.59264487 |
| 12 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.50365342 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.44561475 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.29980000 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.22318145 |
| 16 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.13861255 |
| 17 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.10104199 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.07904524 |
| 19 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 2.06721048 |
| 20 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.05193231 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.97806907 |
| 22 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.96148449 |
| 23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.93869706 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89923159 |
| 25 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.89287118 |
| 26 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.86310361 |
| 27 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.85237917 |
| 28 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.84292198 |
| 29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.83433053 |
| 30 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.76309642 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.75680632 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.71138402 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70749837 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.70566573 |
| 35 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.70512904 |
| 36 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.66137817 |
| 37 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.65922448 |
| 38 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.61116942 |
| 39 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.59335244 |
| 40 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.59335244 |
| 41 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.56663008 |
| 42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.55319497 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.55182153 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.53165196 |
| 45 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.50937532 |
| 46 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48918303 |
| 47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.47042843 |
| 48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45595610 |
| 49 | RXR_22108803_ChIP-Seq_LS180_Human | 1.44987567 |
| 50 | ATF3_27146783_Chip-Seq_COLON_Human | 1.44465439 |
| 51 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.41681603 |
| 52 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.41478130 |
| 53 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.40843643 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38873112 |
| 55 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.37715625 |
| 56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36961792 |
| 57 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36219273 |
| 58 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35802204 |
| 59 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.35305678 |
| 60 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.34784986 |
| 61 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.32765347 |
| 62 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32194682 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30221283 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29108442 |
| 65 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28598022 |
| 66 | KDM2B_26808549_Chip-Seq_K562_Human | 1.27093664 |
| 67 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26568895 |
| 68 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.26360033 |
| 69 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24434404 |
| 70 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23130853 |
| 71 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.22983476 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22836891 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19929729 |
| 74 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.19151989 |
| 75 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.16369053 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14625833 |
| 77 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13936640 |
| 78 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.11465872 |
| 79 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10184947 |
| 80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08467449 |
| 81 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06449355 |
| 82 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.06252032 |
| 83 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.06192430 |
| 84 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04185715 |
| 85 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.04180112 |
| 86 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.04139183 |
| 87 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03180619 |
| 88 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.02774825 |
| 89 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.01563897 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01431495 |
| 91 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 1.01145160 |
| 92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00793770 |
| 93 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.98758178 |
| 94 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.98508434 |
| 95 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98320635 |
| 96 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97998443 |
| 97 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97551994 |
| 98 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96981493 |
| 99 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.96842980 |
| 100 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96557737 |
| 101 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.94527469 |
| 102 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.94052708 |
| 103 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93026630 |
| 104 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.92641849 |
| 105 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92313409 |
| 106 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.91253936 |
| 107 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.90901221 |
| 108 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.88746190 |
| 109 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88736365 |
| 110 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.88074749 |
| 111 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88029782 |
| 112 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.87592679 |
| 113 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.86971163 |
| 114 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.86772352 |
| 115 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86503455 |
| 116 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.86400066 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.85867139 |
| 118 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.85103499 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85049349 |
| 120 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.84721273 |
| 121 | NCOR_22424771_ChIP-Seq_293T_Human | 0.84639647 |
| 122 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84579423 |
| 123 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84366926 |
| 124 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.84049403 |
| 125 | P300_27268052_Chip-Seq_Bcells_Human | 0.82643101 |
| 126 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82068839 |
| 127 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.81768946 |
| 128 | P68_20966046_ChIP-Seq_HELA_Human | 0.81395314 |
| 129 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.80105119 |
| 130 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.79909479 |
| 131 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79828881 |
| 132 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79730207 |
| 133 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.79051105 |
| 134 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.78398247 |
| 135 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.78388279 |
| 136 | SA1_27219007_Chip-Seq_Bcells_Human | 0.77363173 |
| 137 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.77001232 |
| 138 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.76537490 |
| 139 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76021364 |
| 140 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.75414257 |
| 141 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.75174554 |
| 142 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.74315828 |
| 143 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.70069327 |
| 144 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.68707246 |
| 145 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.67544015 |
| 146 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.67174161 |
| 147 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.66612085 |
| 148 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.65698649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 9.40662482 |
| 2 | MP0000579_abnormal_nail_morphology | 6.29472643 |
| 3 | MP0004885_abnormal_endolymph | 5.46884047 |
| 4 | MP0005083_abnormal_biliary_tract | 3.89265720 |
| 5 | MP0002796_impaired_skin_barrier | 3.57900372 |
| 6 | MP0003941_abnormal_skin_development | 3.33594453 |
| 7 | MP0010678_abnormal_skin_adnexa | 3.25641723 |
| 8 | MP0003878_abnormal_ear_physiology | 3.18579514 |
| 9 | MP0005377_hearing/vestibular/ear_phenot | 3.18579514 |
| 10 | MP0003866_abnormal_defecation | 2.88968388 |
| 11 | MP0003436_decreased_susceptibility_to | 2.74345191 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.64601126 |
| 13 | MP0004264_abnormal_extraembryonic_tissu | 2.53863621 |
| 14 | MP0001485_abnormal_pinna_reflex | 2.46811423 |
| 15 | MP0004381_abnormal_hair_follicle | 2.38586718 |
| 16 | MP0000537_abnormal_urethra_morphology | 2.32278620 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.27957572 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.16929047 |
| 19 | MP0001849_ear_inflammation | 2.16863921 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 2.12942435 |
| 21 | MP0005501_abnormal_skin_physiology | 2.09552417 |
| 22 | MP0008004_abnormal_stomach_pH | 1.91149432 |
| 23 | MP0003303_peritoneal_inflammation | 1.90901415 |
| 24 | MP0005409_darkened_coat_color | 1.90515747 |
| 25 | MP0001765_abnormal_ion_homeostasis | 1.88946997 |
| 26 | MP0002909_abnormal_adrenal_gland | 1.88325298 |
| 27 | MP0001188_hyperpigmentation | 1.86857064 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.86644206 |
| 29 | MP0002254_reproductive_system_inflammat | 1.85528614 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.85021944 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.79258912 |
| 32 | MP0004947_skin_inflammation | 1.77006285 |
| 33 | MP0004742_abnormal_vestibular_system | 1.75772717 |
| 34 | MP0002098_abnormal_vibrissa_morphology | 1.75276230 |
| 35 | MP0009785_altered_susceptibility_to | 1.72731422 |
| 36 | MP0003045_fibrosis | 1.72417880 |
| 37 | MP0005275_abnormal_skin_tensile | 1.68834857 |
| 38 | MP0003453_abnormal_keratinocyte_physiol | 1.63252255 |
| 39 | MP0001216_abnormal_epidermal_layer | 1.62992834 |
| 40 | MP0005166_decreased_susceptibility_to | 1.61531065 |
| 41 | MP0006054_spinal_hemorrhage | 1.58960176 |
| 42 | MP0002060_abnormal_skin_morphology | 1.53247663 |
| 43 | MP0000383_abnormal_hair_follicle | 1.49739688 |
| 44 | MP0003075_altered_response_to | 1.47491373 |
| 45 | MP0010771_integument_phenotype | 1.46630037 |
| 46 | MP0001727_abnormal_embryo_implantation | 1.46301007 |
| 47 | MP0005310_abnormal_salivary_gland | 1.37336857 |
| 48 | MP0004272_abnormal_basement_membrane | 1.35434791 |
| 49 | MP0009053_abnormal_anal_canal | 1.29154210 |
| 50 | MP0001881_abnormal_mammary_gland | 1.28250378 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.27965155 |
| 52 | MP0001191_abnormal_skin_condition | 1.24255000 |
| 53 | MP0003011_delayed_dark_adaptation | 1.22018742 |
| 54 | MP0003329_amyloid_beta_deposits | 1.21293391 |
| 55 | MP0000762_abnormal_tongue_morphology | 1.19986792 |
| 56 | MP0000367_abnormal_coat/_hair | 1.19511842 |
| 57 | MP0004185_abnormal_adipocyte_glucose | 1.17561962 |
| 58 | MP0000566_synostosis | 1.16023518 |
| 59 | MP0002139_abnormal_hepatobiliary_system | 1.14981698 |
| 60 | MP0000462_abnormal_digestive_system | 1.10275214 |
| 61 | MP0004858_abnormal_nervous_system | 1.05603782 |
| 62 | MP0009643_abnormal_urine_homeostasis | 1.03143672 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.01734384 |
| 64 | MP0000627_abnormal_mammary_gland | 0.98002407 |
| 65 | MP0004043_abnormal_pH_regulation | 0.96564405 |
| 66 | MP0001851_eye_inflammation | 0.96296733 |
| 67 | MP0001664_abnormal_digestion | 0.95110697 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 0.94383346 |
| 69 | MP0009840_abnormal_foam_cell | 0.93129145 |
| 70 | MP0005076_abnormal_cell_differentiation | 0.91740935 |
| 71 | MP0005636_abnormal_mineral_homeostasis | 0.91215986 |
| 72 | MP0005187_abnormal_penis_morphology | 0.90214051 |
| 73 | MP0000477_abnormal_intestine_morphology | 0.86028970 |
| 74 | MP0002095_abnormal_skin_pigmentation | 0.84995976 |
| 75 | MP0000604_amyloidosis | 0.84122185 |
| 76 | MP0001784_abnormal_fluid_regulation | 0.83811512 |
| 77 | MP0001243_abnormal_dermal_layer | 0.83437409 |
| 78 | MP0005025_abnormal_response_to | 0.82582051 |
| 79 | MP0000467_abnormal_esophagus_morphology | 0.78359741 |
| 80 | MP0009931_abnormal_skin_appearance | 0.77505210 |
| 81 | MP0000377_abnormal_hair_follicle | 0.76622407 |
| 82 | MP0002234_abnormal_pharynx_morphology | 0.76126981 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 0.72611098 |
| 84 | MP0003950_abnormal_plasma_membrane | 0.72025109 |
| 85 | MP0003936_abnormal_reproductive_system | 0.69362390 |
| 86 | MP0005360_urolithiasis | 0.65872730 |
| 87 | MP0003115_abnormal_respiratory_system | 0.64383759 |
| 88 | MP0008872_abnormal_physiological_respon | 0.63852789 |
| 89 | MP0000249_abnormal_blood_vessel | 0.63211886 |
| 90 | MP0010155_abnormal_intestine_physiology | 0.62964122 |
| 91 | MP0002419_abnormal_innate_immunity | 0.61265730 |
| 92 | MP0003448_altered_tumor_morphology | 0.60882380 |
| 93 | MP0001501_abnormal_sleep_pattern | 0.60567384 |
| 94 | MP0002998_abnormal_bone_remodeling | 0.59315474 |
| 95 | MP0003300_gastrointestinal_ulcer | 0.59021334 |
| 96 | MP0000685_abnormal_immune_system | 0.58867562 |
| 97 | MP0004484_altered_response_of | 0.58372310 |
| 98 | MP0003315_abnormal_perineum_morphology | 0.57984977 |
| 99 | MP0001756_abnormal_urination | 0.57977134 |
| 100 | MP0005390_skeleton_phenotype | 0.57961668 |
| 101 | MP0000343_altered_response_to | 0.54572243 |
| 102 | MP0005381_digestive/alimentary_phenotyp | 0.53275828 |
| 103 | MP0002168_other_aberrant_phenotype | 0.53078479 |
| 104 | MP0005165_increased_susceptibility_to | 0.53049059 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.52995917 |
| 106 | MP0005023_abnormal_wound_healing | 0.52264556 |
| 107 | MP0005319_abnormal_enzyme/_coenzyme | 0.50382596 |
| 108 | MP0002295_abnormal_pulmonary_circulatio | 0.50310556 |
| 109 | MP0006082_CNS_inflammation | 0.49591241 |
| 110 | MP0001663_abnormal_digestive_system | 0.49438522 |
| 111 | MP0000609_abnormal_liver_physiology | 0.46050761 |
| 112 | MP0000647_abnormal_sebaceous_gland | 0.45899698 |
| 113 | MP0001440_abnormal_grooming_behavior | 0.45841119 |
| 114 | MP0003638_abnormal_response/metabolism_ | 0.45638360 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.44803161 |
| 116 | MP0010368_abnormal_lymphatic_system | 0.44256077 |
| 117 | MP0003690_abnormal_glial_cell | 0.44088772 |
| 118 | MP0000427_abnormal_hair_cycle | 0.42396492 |
| 119 | MP0005508_abnormal_skeleton_morphology | 0.41345357 |
| 120 | MP0002138_abnormal_hepatobiliary_system | 0.40958063 |
| 121 | MP0008469_abnormal_protein_level | 0.40821716 |
| 122 | MP0002896_abnormal_bone_mineralization | 0.39611083 |
| 123 | MP0005375_adipose_tissue_phenotype | 0.34476243 |
| 124 | MP0009379_abnormal_foot_pigmentation | 0.34383583 |
| 125 | MP0002177_abnormal_outer_ear | 0.34368958 |
| 126 | MP0002111_abnormal_tail_morphology | 0.31482146 |
| 127 | MP0003755_abnormal_palate_morphology | 0.31392493 |
| 128 | MP0001340_abnormal_eyelid_morphology | 0.30574947 |
| 129 | MP0004197_abnormal_fetal_growth/weight/ | 0.28499583 |
| 130 | MP0010030_abnormal_orbit_morphology | 0.25764423 |
| 131 | MP0002133_abnormal_respiratory_system | 0.25180538 |
| 132 | MP0005388_respiratory_system_phenotype | 0.25180538 |
| 133 | MP0005503_abnormal_tendon_morphology | 0.24462320 |
| 134 | MP0003763_abnormal_thymus_physiology | 0.23805279 |
| 135 | MP0008260_abnormal_autophagy | 0.23436855 |
| 136 | MP0009333_abnormal_splenocyte_physiolog | 0.22675368 |
| 137 | MP0001177_atelectasis | 0.22629776 |
| 138 | MP0000003_abnormal_adipose_tissue | 0.22387001 |
| 139 | MP0001502_abnormal_circadian_rhythm | 0.19684216 |
| 140 | MP0005075_abnormal_melanosome_morpholog | 0.17841112 |
| 141 | MP0000470_abnormal_stomach_morphology | 0.17478205 |
| 142 | MP0002282_abnormal_trachea_morphology | 0.16796032 |
| 143 | MP0003828_pulmonary_edema | 0.15800889 |
| 144 | MP0003724_increased_susceptibility_to | 0.13160874 |
| 145 | MP0008569_lethality_at_weaning | 0.13062942 |
| 146 | MP0004510_myositis | 0.12498678 |
| 147 | MP0009672_abnormal_birth_weight | 0.11329357 |
| 148 | MP0001186_pigmentation_phenotype | 0.11215078 |
| 149 | MP0008438_abnormal_cutaneous_collagen | 0.10518402 |
| 150 | MP0001905_abnormal_dopamine_level | 0.09686337 |
| 151 | MP0003221_abnormal_cardiomyocyte_apopto | 0.09600043 |
| 152 | MP0003633_abnormal_nervous_system | 0.08663688 |
| 153 | MP0008789_abnormal_olfactory_epithelium | 0.08636221 |
| 154 | MP0002006_tumorigenesis | 0.07860022 |
| 155 | MP0005193_abnormal_anterior_eye | 0.07056204 |
| 156 | MP0009765_abnormal_xenobiotic_induced | 0.06634671 |
| 157 | MP0002877_abnormal_melanocyte_morpholog | 0.05825618 |
| 158 | MP0005499_abnormal_olfactory_system | 0.04992816 |
| 159 | MP0005394_taste/olfaction_phenotype | 0.04992816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital sensorineural hearing impairment (HP:0008527) | 9.15536610 |
| 2 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 9.13912179 |
| 3 | Increased IgE level (HP:0003212) | 8.95215185 |
| 4 | Palmar hyperkeratosis (HP:0010765) | 8.68642490 |
| 5 | Oral leukoplakia (HP:0002745) | 8.48164536 |
| 6 | Onycholysis (HP:0001806) | 8.34379933 |
| 7 | Erythroderma (HP:0001019) | 8.22300870 |
| 8 | Morphological abnormality of the inner ear (HP:0011390) | 7.25308050 |
| 9 | Parakeratosis (HP:0001036) | 7.03997471 |
| 10 | Erythema (HP:0010783) | 6.25610520 |
| 11 | Thick nail (HP:0001805) | 6.24520872 |
| 12 | Milia (HP:0001056) | 5.96747981 |
| 13 | Corneal erosion (HP:0200020) | 5.77561982 |
| 14 | Atrophic scars (HP:0001075) | 5.76867021 |
| 15 | Fragile nails (HP:0001808) | 5.54636774 |
| 16 | Pili torti (HP:0003777) | 5.40056589 |
| 17 | Alopecia of scalp (HP:0002293) | 5.25258376 |
| 18 | Hyperparathyroidism (HP:0000843) | 5.04632526 |
| 19 | Gout (HP:0001997) | 4.98359322 |
| 20 | Hypotrichosis (HP:0001006) | 4.96464903 |
| 21 | Gangrene (HP:0100758) | 4.90321961 |
| 22 | Ectropion (HP:0000656) | 4.84339568 |
| 23 | Abnormality of secondary sexual hair (HP:0009888) | 4.54278717 |
| 24 | Abnormality of the axillary hair (HP:0100134) | 4.54278717 |
| 25 | Follicular hyperkeratosis (HP:0007502) | 4.36178840 |
| 26 | Tracheal stenosis (HP:0002777) | 4.29035287 |
| 27 | Palmoplantar keratoderma (HP:0000982) | 4.28794299 |
| 28 | Goiter (HP:0000853) | 4.13583719 |
| 29 | Plantar hyperkeratosis (HP:0007556) | 3.97674060 |
| 30 | Curly hair (HP:0002212) | 3.95098626 |
| 31 | Thyroid carcinoma (HP:0002890) | 3.89531433 |
| 32 | Abnormal hair laboratory examination (HP:0003328) | 3.77581022 |
| 33 | Pustule (HP:0200039) | 3.76868621 |
| 34 | Conjunctival hamartoma (HP:0100780) | 3.66885412 |
| 35 | Right ventricular cardiomyopathy (HP:0011663) | 3.66171390 |
| 36 | Split foot (HP:0001839) | 3.44416099 |
| 37 | Lip pit (HP:0100267) | 3.38036214 |
| 38 | Complement deficiency (HP:0004431) | 3.24798872 |
| 39 | Furrowed tongue (HP:0000221) | 3.23596500 |
| 40 | Glomerulonephritis (HP:0000099) | 3.18259501 |
| 41 | Absent eyelashes (HP:0000561) | 3.15871419 |
| 42 | Absent hair (HP:0002298) | 3.12990090 |
| 43 | Glomerulosclerosis (HP:0000096) | 3.10532402 |
| 44 | Pruritus (HP:0000989) | 3.10418682 |
| 45 | Sparse eyelashes (HP:0000653) | 3.08519961 |
| 46 | Deep venous thrombosis (HP:0002625) | 3.02003526 |
| 47 | Lack of skin elasticity (HP:0100679) | 3.01697045 |
| 48 | Nail dystrophy (HP:0008404) | 2.91863307 |
| 49 | Laryngomalacia (HP:0001601) | 2.74149039 |
| 50 | Hypoplasia of dental enamel (HP:0006297) | 2.68581813 |
| 51 | Ankyloglossia (HP:0010296) | 2.66067696 |
| 52 | Vertigo (HP:0002321) | 2.63910878 |
| 53 | Abnormality of the salivary glands (HP:0010286) | 2.60451147 |
| 54 | Hyperuricemia (HP:0002149) | 2.59918943 |
| 55 | Increased purine levels (HP:0004368) | 2.59918943 |
| 56 | Paralysis (HP:0003470) | 2.57969539 |
| 57 | Hemorrhage of the eye (HP:0011885) | 2.57790230 |
| 58 | Sparse scalp hair (HP:0002209) | 2.55660997 |
| 59 | Abnormality of complement system (HP:0005339) | 2.53222909 |
| 60 | Autoamputation (HP:0001218) | 2.49607893 |
| 61 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.47907733 |
| 62 | Micronodular cirrhosis (HP:0001413) | 2.45058290 |
| 63 | Hypergammaglobulinemia (HP:0010702) | 2.39792153 |
| 64 | Hamartoma of the eye (HP:0010568) | 2.37764832 |
| 65 | Focal segmental glomerulosclerosis (HP:0000097) | 2.30086890 |
| 66 | Urticaria (HP:0001025) | 2.29920628 |
| 67 | Intrahepatic cholestasis (HP:0001406) | 2.29400519 |
| 68 | Nephritis (HP:0000123) | 2.24879107 |
| 69 | Multifactorial inheritance (HP:0001426) | 2.23482861 |
| 70 | Hyperhidrosis (HP:0000975) | 2.22715679 |
| 71 | Brittle hair (HP:0002299) | 2.20353490 |
| 72 | Axonal loss (HP:0003447) | 2.19115557 |
| 73 | Corneal dystrophy (HP:0001131) | 2.16498165 |
| 74 | Abnormal blistering of the skin (HP:0008066) | 2.16232728 |
| 75 | Vascular calcification (HP:0004934) | 2.16160424 |
| 76 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.10645468 |
| 77 | Sepsis (HP:0100806) | 2.07890977 |
| 78 | Interstitial pulmonary disease (HP:0006530) | 2.07432208 |
| 79 | Fragile skin (HP:0001030) | 2.06520333 |
| 80 | Abnormality of macular pigmentation (HP:0008002) | 2.05752141 |
| 81 | Abnormality of oral frenula (HP:0000190) | 2.03855548 |
| 82 | Cheilitis (HP:0100825) | 2.03018074 |
| 83 | Cardiovascular calcification (HP:0011915) | 2.02230707 |
| 84 | Tubulointerstitial fibrosis (HP:0005576) | 2.00597848 |
| 85 | Abnormality of purine metabolism (HP:0004352) | 2.00037788 |
| 86 | Abnormality of nail color (HP:0100643) | 14.6680749 |
| 87 | Abnormality of cochlea (HP:0000375) | 10.1429871 |
| 88 | Natal tooth (HP:0000695) | 1.95695758 |
| 89 | Radial bowing (HP:0002986) | 1.95487676 |
| 90 | Anonychia (HP:0001798) | 1.94218777 |
| 91 | Recurrent corneal erosions (HP:0000495) | 1.93749000 |
| 92 | Tubulointerstitial nephritis (HP:0001970) | 1.93527644 |
| 93 | Keratoconjunctivitis sicca (HP:0001097) | 1.92699527 |
| 94 | Central scotoma (HP:0000603) | 1.91502448 |
| 95 | Subacute progressive viral hepatitis (HP:0006572) | 1.90752069 |
| 96 | Neoplasm of the thyroid gland (HP:0100031) | 1.89653606 |
| 97 | Blepharitis (HP:0000498) | 1.89406654 |
| 98 | Fibular aplasia (HP:0002990) | 1.87418642 |
| 99 | Ridged nail (HP:0001807) | 1.86549730 |
| 100 | Verrucae (HP:0200043) | 1.83570414 |
| 101 | Papilloma (HP:0012740) | 1.83570414 |
| 102 | Renal salt wasting (HP:0000127) | 1.80201920 |
| 103 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 1.80123090 |
| 104 | Xanthomatosis (HP:0000991) | 1.79448622 |
| 105 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.78459752 |
| 106 | Hydroureter (HP:0000072) | 1.78207217 |
| 107 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.77746882 |
| 108 | Carious teeth (HP:0000670) | 1.77679153 |
| 109 | Esophageal atresia (HP:0002032) | 1.76921363 |
| 110 | Tubular atrophy (HP:0000092) | 1.75293758 |
| 111 | Keratoconjunctivitis (HP:0001096) | 1.75272260 |
| 112 | Bowed forearm bones (HP:0003956) | 1.73235331 |
| 113 | Bowing of the arm (HP:0006488) | 1.73235331 |
| 114 | Bronchomalacia (HP:0002780) | 1.72562591 |
| 115 | Recurrent bacterial skin infections (HP:0005406) | 1.70794296 |
| 116 | Skin ulcer (HP:0200042) | 1.68923418 |
| 117 | Advanced eruption of teeth (HP:0006288) | 1.68603316 |
| 118 | Esophageal varix (HP:0002040) | 1.67793503 |
| 119 | Ventricular tachycardia (HP:0004756) | 1.67730555 |
| 120 | Reticulocytosis (HP:0001923) | 1.67499132 |
| 121 | Dry skin (HP:0000958) | 1.66143704 |
| 122 | Germ cell neoplasia (HP:0100728) | 1.65868414 |
| 123 | Abnormality of placental membranes (HP:0011409) | 1.65239414 |
| 124 | Amniotic constriction ring (HP:0009775) | 1.65239414 |
| 125 | Systemic lupus erythematosus (HP:0002725) | 1.63411135 |
| 126 | Abnormality of the gastric mucosa (HP:0004295) | 1.63221784 |
| 127 | Spastic diplegia (HP:0001264) | 1.62335117 |
| 128 | Ureteral stenosis (HP:0000071) | 1.61742679 |
| 129 | Cone-rod dystrophy (HP:0000548) | 1.60190613 |
| 130 | Vertebral clefting (HP:0008428) | 1.59148872 |
| 131 | Abnormality of the fingernails (HP:0001231) | 1.58532331 |
| 132 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.57976866 |
| 133 | Abnormality of hair growth rate (HP:0011363) | 1.54812335 |
| 134 | Slow-growing hair (HP:0002217) | 1.54812335 |
| 135 | Shallow orbits (HP:0000586) | 1.54113032 |
| 136 | Hypoplastic toenails (HP:0001800) | 1.53921351 |
| 137 | Abnormal vertebral ossification (HP:0100569) | 1.52554469 |
| 138 | Synostosis involving the elbow (HP:0003938) | 1.52447702 |
| 139 | Humeroradial synostosis (HP:0003041) | 1.52447702 |
| 140 | Death in infancy (HP:0001522) | 1.52116276 |
| 141 | Cervical subluxation (HP:0003308) | 1.50302897 |
| 142 | Melanocytic nevus (HP:0000995) | 1.48391660 |
| 143 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.47674074 |
| 144 | Dehydration (HP:0001944) | 1.46125723 |
| 145 | Woolly hair (HP:0002224) | 1.45438791 |
| 146 | Eczematoid dermatitis (HP:0000976) | 1.45149311 |
| 147 | Abnormality of iron homeostasis (HP:0011031) | 1.45115847 |
| 148 | Ureteral obstruction (HP:0006000) | 1.44729983 |
| 149 | Fine hair (HP:0002213) | 1.44492981 |
| 150 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.43607868 |
| 151 | Villous atrophy (HP:0011473) | 1.43607868 |
| 152 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.42834030 |
| 153 | Preauricular skin tag (HP:0000384) | 1.42415128 |
| 154 | Hypohidrosis (HP:0000966) | 1.42273483 |
| 155 | Hoarse voice (HP:0001609) | 1.42222879 |
| 156 | Ileus (HP:0002595) | 1.41836223 |
| 157 | Bicornuate uterus (HP:0000813) | 1.41823595 |
| 158 | Vacuolated lymphocytes (HP:0001922) | 1.41389254 |
| 159 | Palmoplantar hyperkeratosis (HP:0000972) | 1.41245432 |
| 160 | Cerebral inclusion bodies (HP:0100314) | 1.41201780 |
| 161 | Polycythemia (HP:0001901) | 1.40675771 |
| 162 | Hypoplastic labia majora (HP:0000059) | 1.38944259 |
| 163 | Acanthosis nigricans (HP:0000956) | 1.38906062 |
| 164 | Dry hair (HP:0011359) | 1.37055755 |
| 165 | Everted lower lip vermilion (HP:0000232) | 1.29583862 |
| 166 | Abnormality of the labia majora (HP:0012881) | 1.25727010 |
| 167 | Skin tags (HP:0010609) | 1.22151798 |
| 168 | Fatigable weakness (HP:0003473) | 1.20922365 |
| 169 | Abnormality of the neuromuscular junction (HP:0003398) | 1.20922365 |
| 170 | Popliteal pterygium (HP:0009756) | 1.19540866 |
| 171 | Selective tooth agenesis (HP:0001592) | 1.17417184 |
| 172 | Generalized hyperpigmentation (HP:0007440) | 1.16217018 |
| 173 | Squamous cell carcinoma (HP:0002860) | 1.15922661 |
| 174 | Acanthocytosis (HP:0001927) | 1.15864964 |
| 175 | Hamartoma (HP:0010566) | 1.10140756 |
| 176 | Recurrent skin infections (HP:0001581) | 1.07229798 |
| 177 | Xerostomia (HP:0000217) | 1.05040519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR1 | 3.62059156 |
| 2 | STK24 | 3.50027642 |
| 3 | MAP3K6 | 3.20951988 |
| 4 | MST4 | 3.09688123 |
| 5 | SGK494 | 3.00770171 |
| 6 | SGK223 | 3.00770171 |
| 7 | EPHB2 | 2.84534272 |
| 8 | MST1R | 2.75905211 |
| 9 | FRK | 2.49965336 |
| 10 | IRAK1 | 2.05695494 |
| 11 | EPHA2 | 11.7333814 |
| 12 | MAPK15 | 1.99198226 |
| 13 | MAP3K9 | 1.98440175 |
| 14 | PTK6 | 1.93515661 |
| 15 | FER | 1.88152177 |
| 16 | EPHB1 | 1.87772496 |
| 17 | LMTK2 | 1.80318767 |
| 18 | TSSK6 | 1.79987397 |
| 19 | TRIB3 | 1.72451741 |
| 20 | PTK2 | 1.59438253 |
| 21 | PKN2 | 1.54945750 |
| 22 | BMX | 1.49233449 |
| 23 | NME1 | 1.38908618 |
| 24 | RIPK1 | 1.31512991 |
| 25 | LATS1 | 1.30688708 |
| 26 | IRAK3 | 1.29499931 |
| 27 | MAP3K2 | 1.28254604 |
| 28 | MAP2K2 | 1.28074749 |
| 29 | MET | 1.20809412 |
| 30 | TBK1 | 1.17811919 |
| 31 | SIK1 | 1.16653672 |
| 32 | PAK4 | 1.14961815 |
| 33 | LRRK2 | 1.08262304 |
| 34 | PIM2 | 1.00661738 |
| 35 | IRAK4 | 0.99710264 |
| 36 | JAK3 | 0.99253556 |
| 37 | EEF2K | 0.98481483 |
| 38 | RPS6KB2 | 0.97565472 |
| 39 | MAPKAPK5 | 0.96975479 |
| 40 | MAP2K1 | 0.95728118 |
| 41 | IRAK2 | 0.95687781 |
| 42 | DDR2 | 0.94633024 |
| 43 | ZAP70 | 0.92775948 |
| 44 | MAPK7 | 0.90652783 |
| 45 | KSR2 | 0.89843300 |
| 46 | ERN1 | 0.89357293 |
| 47 | MAP3K10 | 0.87819537 |
| 48 | STK10 | 0.86794196 |
| 49 | ERBB2 | 0.86488988 |
| 50 | PRPF4B | 0.86244903 |
| 51 | STK38L | 0.86064355 |
| 52 | MARK2 | 0.85786903 |
| 53 | FGFR4 | 0.85489792 |
| 54 | PDGFRB | 0.82213444 |
| 55 | MAP3K1 | 0.79314341 |
| 56 | MAP3K14 | 0.76535488 |
| 57 | EPHA3 | 0.75351928 |
| 58 | STK38 | 0.74363049 |
| 59 | WNK1 | 0.72382209 |
| 60 | PRKD2 | 0.71260806 |
| 61 | PAK3 | 0.71173817 |
| 62 | ERBB4 | 0.70614739 |
| 63 | ADRBK1 | 0.70070796 |
| 64 | CDK12 | 0.68730687 |
| 65 | MAP2K6 | 0.68703360 |
| 66 | STK3 | 0.67476223 |
| 67 | ALK | 0.64390904 |
| 68 | MATK | 0.62967283 |
| 69 | SGK1 | 0.61645701 |
| 70 | NLK | 0.60228641 |
| 71 | MAPKAPK3 | 0.59583306 |
| 72 | TYK2 | 0.59097022 |
| 73 | TESK1 | 0.58612535 |
| 74 | MAP3K3 | 0.57646319 |
| 75 | PRKG2 | 0.56280216 |
| 76 | MAP3K13 | 0.56073834 |
| 77 | TAOK3 | 0.55914534 |
| 78 | SRC | 0.55013120 |
| 79 | KIT | 0.53916490 |
| 80 | DMPK | 0.52657780 |
| 81 | SIK3 | 0.52605231 |
| 82 | PRKCI | 0.51738747 |
| 83 | MAPKAPK2 | 0.51457920 |
| 84 | BLK | 0.51115176 |
| 85 | HCK | 0.50767225 |
| 86 | KSR1 | 0.49574788 |
| 87 | TAOK2 | 0.48969202 |
| 88 | PAK1 | 0.48503985 |
| 89 | TYRO3 | 0.46509004 |
| 90 | CDC42BPA | 0.45909741 |
| 91 | MAP3K8 | 0.45550040 |
| 92 | ERBB3 | 0.45327840 |
| 93 | EGFR | 0.44737394 |
| 94 | TAOK1 | 0.43931289 |
| 95 | SGK3 | 0.43486215 |
| 96 | MAP3K11 | 0.43421401 |
| 97 | IKBKE | 0.42441394 |
| 98 | MAP3K12 | 0.42070497 |
| 99 | SGK2 | 0.42022113 |
| 100 | HIPK2 | 0.40408831 |
| 101 | PDGFRA | 0.40248748 |
| 102 | FGFR1 | 0.39346524 |
| 103 | TRPM7 | 0.39232795 |
| 104 | TTN | 0.38865690 |
| 105 | GSK3A | 0.36730213 |
| 106 | PAK2 | 0.36644095 |
| 107 | MAP3K5 | 0.36267483 |
| 108 | CSK | 0.35010186 |
| 109 | MOS | 0.34376047 |
| 110 | BCR | 0.33246264 |
| 111 | NTRK1 | 0.31780426 |
| 112 | IKBKB | 0.31492904 |
| 113 | CDK19 | 0.30768636 |
| 114 | ROCK2 | 0.30455757 |
| 115 | TGFBR2 | 0.30287190 |
| 116 | TESK2 | 0.30160043 |
| 117 | PRKD1 | 0.28748486 |
| 118 | PKN1 | 0.28500711 |
| 119 | FGR | 0.28444933 |
| 120 | FLT3 | 0.28297935 |
| 121 | FYN | 0.25844186 |
| 122 | TXK | 0.25481675 |
| 123 | RPS6KA1 | 0.25274032 |
| 124 | PBK | 0.25013550 |
| 125 | CAMK2B | 0.24636953 |
| 126 | JAK1 | 0.24428091 |
| 127 | CSNK1E | 0.22933806 |
| 128 | MAP3K7 | 0.22868274 |
| 129 | CDK6 | 0.22808345 |
| 130 | CSNK1A1L | 0.22682854 |
| 131 | RET | 0.22658974 |
| 132 | DYRK2 | 0.21593429 |
| 133 | PRKAA2 | 0.21070600 |
| 134 | CSNK1G3 | 0.20435763 |
| 135 | PRKCE | 0.19707285 |
| 136 | LATS2 | 0.19124668 |
| 137 | FGFR3 | 0.19123037 |
| 138 | MAPK4 | 0.18385456 |
| 139 | ABL2 | 0.18369953 |
| 140 | ICK | 0.18349148 |
| 141 | MTOR | 0.18237676 |
| 142 | ABL1 | 0.18041631 |
| 143 | CDK5 | 0.17852916 |
| 144 | PAK6 | 0.17319936 |
| 145 | GRK6 | 0.16941675 |
| 146 | EPHA4 | 0.15719602 |
| 147 | JAK2 | 0.15715380 |
| 148 | CAMK2D | 0.15401322 |
| 149 | RPS6KA2 | 0.15155705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 4.33441044 |
| 2 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 4.29229889 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 3.59565998 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.51569477 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.47548651 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.43983279 |
| 7 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 2.32147084 |
| 8 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 2.13719009 |
| 9 | Long-term depression_Homo sapiens_hsa04730 | 1.88594035 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.84274142 |
| 11 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.82966814 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.79565488 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.70030439 |
| 14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68809744 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.57962091 |
| 16 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.57730394 |
| 17 | Tight junction_Homo sapiens_hsa04530 | 1.55816256 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.50496269 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.49689672 |
| 20 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.44968570 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.42961520 |
| 22 | Amoebiasis_Homo sapiens_hsa05146 | 1.40148931 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37476174 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.34373083 |
| 25 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.32498795 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.28917891 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28515171 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.26648745 |
| 29 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.26376803 |
| 30 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.15875442 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.14692190 |
| 32 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14488266 |
| 33 | Circadian rhythm_Homo sapiens_hsa04710 | 1.12682407 |
| 34 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09020475 |
| 35 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.05854799 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.05522420 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.05115911 |
| 38 | Bladder cancer_Homo sapiens_hsa05219 | 1.05095661 |
| 39 | Histidine metabolism_Homo sapiens_hsa00340 | 1.03837363 |
| 40 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.03746668 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03560025 |
| 42 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.00052044 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98216286 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 0.97633377 |
| 45 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.97179476 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 0.96654460 |
| 47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.95648931 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.94991461 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.88094790 |
| 50 | Adherens junction_Homo sapiens_hsa04520 | 0.86704976 |
| 51 | Focal adhesion_Homo sapiens_hsa04510 | 0.83270621 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79937482 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79094598 |
| 54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75918550 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74739083 |
| 56 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.74655400 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74332836 |
| 58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.73915987 |
| 59 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.73848406 |
| 60 | Influenza A_Homo sapiens_hsa05164 | 0.72836147 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71723496 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.70716151 |
| 63 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.69543536 |
| 64 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68880823 |
| 65 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68429212 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67633712 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67546981 |
| 68 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.66713668 |
| 69 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.66429821 |
| 70 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.66164131 |
| 71 | Renin secretion_Homo sapiens_hsa04924 | 0.65591562 |
| 72 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62651216 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62133845 |
| 74 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59966330 |
| 75 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59256142 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58647106 |
| 77 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.57985820 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56773013 |
| 79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56394840 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56126613 |
| 81 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55763700 |
| 82 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.54764959 |
| 83 | Malaria_Homo sapiens_hsa05144 | 0.54520275 |
| 84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54336098 |
| 85 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54254793 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53131247 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.52913439 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50967549 |
| 89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50643044 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48436609 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46789225 |
| 92 | Tuberculosis_Homo sapiens_hsa05152 | 0.45183511 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44979073 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44645016 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.43965628 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43454382 |
| 97 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43218777 |
| 98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42458303 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40737235 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40675513 |
| 101 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40178767 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.40140638 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39957069 |
| 104 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.38981696 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.38722729 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38576850 |
| 107 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.38123724 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.36492628 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35584072 |
| 110 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.35173982 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.34165146 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34041190 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32951720 |
| 114 | Axon guidance_Homo sapiens_hsa04360 | 0.32352613 |
| 115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32241183 |
| 116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.31802700 |
| 117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.31447984 |
| 118 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.30554531 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30055813 |
| 120 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.30047373 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29998512 |
| 122 | Long-term potentiation_Homo sapiens_hsa04720 | 0.29944290 |
| 123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28355374 |
| 124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.27608047 |
| 125 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27455311 |
| 126 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.26921942 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.26883262 |
| 128 | Melanogenesis_Homo sapiens_hsa04916 | 0.26846848 |
| 129 | Carbon metabolism_Homo sapiens_hsa01200 | 0.26654469 |
| 130 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.26421957 |
| 131 | Retinol metabolism_Homo sapiens_hsa00830 | 0.26114894 |
| 132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.25752362 |
| 133 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.25440619 |
| 134 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.25256158 |
| 135 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24639163 |
| 136 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24474664 |
| 137 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.23959487 |
| 138 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.21024823 |
| 139 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.18183476 |
| 140 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.17707866 |
| 141 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.15765404 |
| 142 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.13107942 |
| 143 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.12084476 |
| 144 | Phagosome_Homo sapiens_hsa04145 | 0.11255227 |
| 145 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.11164182 |
| 146 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.10876777 |

